Phase I Study to Assess the Absorption, Metabolism, and Excretion of [14C] Labeled SPN-810M
Clinical trial NCT02023606 · COMPLETED
Trial details
- NCT number
- NCT02023606
- Sponsor
- Supernus Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2013-11-01
- Primary completion
- 2013-12-01
- Enrollment
- 7
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.